Online Analysis Of Somatic Mutations

Mutation Prevalence

With this option you can retrieve the proportion of tumors that carry a TP53 gene mutation. You can choose to display the results by tumor site (Topography), tumor type (Morphology), or by Country. The data can be downloaded from the chart window.

Select cancer:
Topography:	Morphology:
Select population:
Country:	Population:	Development:
Select method:
Start_material:	Exons analyzed:
Select graph to display:

In the scrollbar menus, multiple selection is possible by using the Ctrl key.

ADRENAL GLAND
ANUS
BILIARY TRACT
BLADDER
BONES (limbs)
BONES (other)
BRAIN
BREAST
CERVIX UTERI
COLON
COLORECTUM, NOS
CORPUS UTERI
ENDOCRINE GLANDS, NOS
ESOPHAGUS
EYE AND ADNEXA
FEMALE GENITAL ORG., NOS
GALLBLADDER
GUM
HEAD&NECK, NOS
HEART/MED/PLEURA
HEMATOP. SYSTEM
HYPOPHARYNX
KIDNEY
LARYNX
LIP
LIVER
LUNG
LYMPH NODES
MENINGES
MOUTH (floor)
MOUTH (other)
NASAL CAVITY
NASOPHARYNX
NERVES
OROPHARYNX
OTHER ENDOCRINE Gl.
OTHER FEMALE GEN. ORG.
OTHER HEAD&NECK
OTHER RESPIR. SYST.
OTHER SITES
OVARY
PALATE
PANCREAS
PAROTID GLAND
PENIS
PERITONEUM
PLACENTA
PROSTATE
RECTUM
RENAL PELVIS
SALIVARY GLAND
SINUSES
SKIN
SMALL INTESTINE
SOFT TISSUES
SPINAL CORD
STOMACH
TESTIS
THYMUS
THYROID
TONGUE (base)
TONGUE (other)
TONSIL
UNKNOWN SITE
URETER
URINARY TRACT, NOS
UTERUS
VAGINA
VULVA

Acinar cell carcinoma
Acute leukemia, NOS
Acute myeloid leukemia, minimal differentiation
Acute myeloid leukemia, NOS
Adenocarcinoma, diffuse type (C16._)
Adenocarcinoma, intestinal type (C16._)
Adenocarcinoma, NOS
Adenoid cystic carcinoma
Adenoma, NOS
Adenosquamous carcinoma
Adrenal cortical adenoma, NOS (C74.0)
Adrenal cortical carcinoma (C74.0)
Adult T-cell leukemia/lymphoma (HTLV-1 positive)
Ameloblastoma, NOS
Anaplastic large cell lymphoma, T cell and null cell type
Astrocytoma, anaplastic (C71._)
Astrocytoma, NOS (C71._)
Atypical carcinoid tumor
Atypical fibrous histiocytoma
Barrett's esophagus
Basal cell carcinoma, NOS (C44._)
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma
Bowen disease (C44._)
Bronchiolo-alveolar adenocarcinoma (C34._)
Bronchiolo-alveolar carcinoma, mixed mucinous and non-mucinous(C34._)
Burkitt cell leukemia
Burkitt lymphoma, NOS
Cancer, NOS
Carcinoid tumor of uncertain malignant potential
Carcinoid tumor, NOS (except of Appendix M-8240/1)
Carcinoma in pleomorphic adenoma (C07._, C08._)
Carcinoma in situ, NOS
Carcinoma with osteoclast-like giant cells
Carcinoma, anaplastic, NOS
Carcinoma, metastatic, NOS
Carcinoma, NOS
Carcinoma, undifferentiated, NOS
Carcinosarcoma, NOS
Central neurocytoma
Cholangiocarcinoma (C22.1, C24.0)
Chondrosarcoma, NOS (C40._, C41._)
Chordoma, NOS
Choroid plexus carcinoma (C71.5)
Choroid plexus papilloma, NOS (C71.5)
Chronic myeloid leukemia, NOS
Chronic myelomonocytic leukemia, NOS
Chronic myeloproliferative disease, NOS
Clear cell adenocarcinoma, NOS
Clear cell sarcoma of kidney (C64.9)
Clear cell sarcoma, NOS (except of Kidney M-8964/3)
Combined hepatocellular carcinoma and cholangiocarcinoma (C22.0)
Combined small cell carcinoma
Cutaneous T-cell lymphoma, NOS (C44._)
Cystadenocarcinoma, NOS
Cystadenoma, NOS
Dermatofibrosarcoma, NOS (C44._)
Ductal carcinoma in situ, solid type (C50._)
Dysplasia, NOS
Dysplasia, severe
Dysplastic nevus (C44._)
Embryonal sarcoma
Endometrioid adenocarcinoma, NOS
Endometriosis, NOS
Ependymoma, anaplastic (C71._)
Ependymoma, NOS (C71._)
Epithelial tumor, benign
Esophagitis
Essential thrombocythemia
Ewing sarcoma
Fibrillary astrocytoma (C71._)
Fibrosarcoma, NOS
Fibrosis, NOS
Follicular adenocarcinoma, NOS (C73.9)
Follicular adenoma (C73.9)
Follicular lymphoma, grade 3
Follicular lymphoma, NOS
Gastrointestinal stromal tumor, NOS
Gemistocytic astrocytoma (C71._)
Germinoma
Giant cell glioblastoma (C71._)
Glandular intraepithelial neoplasia, grade III
Glioblastoma, NOS (C71._)
Glioma, malignant (C71._)
Gliomatosis cerebri (C71._)
Gliosarcoma (C71._)
Goblet cell carcinoid
Hairy cell leukemia (C42.1)
Hemangioblastoma
Hemangiopericytoma, NOS
Hemangiosarcoma
Hepatoblastoma (C22.0)
Hepatocellular carcinoma, NOS (C22.0)
Hodgkin lymphoma, NOS
Hydatidiform mole, NOS (C58.9)
Hyperplasia, glandular
Hyperplasia, NOS
Infiltrating duct carcinoma, NOS (C50._)
Inflammatory carcinoma (C50._)
Inflammatory pseudotumor
Insulinoma, malignant (C25._)
Insulinoma, NOS (C25._)
Intraductal carcinoma, noninfiltrating, NOS
Intraductal papillary-mucinous adenoma (C25._)
Intraductal papillary-mucinous carcinoma, non invasive (C25._)
Islet cell tumor, NOS (C25._)
Kaposi sarcoma
Keloid
Keratoacanthoma, NOS
Keratosis, actinic
Keratosis, NOS
Large cell carcinoma, NOS
Leiomyoma, NOS
Leiomyosarcoma, NOS
Lentigo maligna melanoma (C44._)
Leucoplakia, NOS
Leukemia, NOS
Liposarcoma, NOS
Lobular carcinoma, NOS (C50._)
Lymphoepithelial carcinoma
Lymphoid leukemia, NOS
Malignant fibrous histiocytoma
Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS
Malignant lymphoma, large B-cell, diffuse, NOS
Malignant lymphoma, non-Hodgkin, NOS
Malignant lymphoma, NOS
Malignant lymphoma, small B lymphocytic, NOS
Malignant melanoma, NOS
Malignant peripheral nerve sheath tumor
Malignant rhabdoid tumor
Mantle cell lymphoma
Marginal zone B-cell lymphoma, NOS
Mature T-cell lymphoma, NOS
Medullary carcinoma, NOS
Medulloblastoma, NOS (C71.6)
Meningioma, malignant
Meningioma, NOS
Mesodermal mixed tumor
Mesothelioma, malignant
Metaplasia
Metaplastic carcinoma, NOS
Mixed cell adenocarcinoma
Mixed glioma (C71._)
Mixed liposarcoma
Mucinous adenocarcinoma
Mucinous adenoma
Mucoepidermoid carcinoma
Mucosal lentiginous melanoma
Mullerian mixed tumor (C54._)
Multiple myeloma (C42.1)
Mycosis fungoides (C44._)
Myelodysplastic syndrome with 5q deletion
Myelodysplastic syndrome, NOS
Myoepithelioma
Myofibroblastic tumor, NOS
Neoplasm, benign
Neoplasm, NOS
Nephroblastoma, NOS (C64.9)
Neurilemoma, NOS
Neuroblastoma, NOS
Neuroendocrine carcinoma, NOS
NK/T-cell lymphoma, nasal and nasal-type
Nodular melanoma (C44._)
Non-small cell carcinoma (C34._)
Normal tissue
Oligodendroglioma, anaplastic (C71._)
Oligodendroglioma, NOS (C71._)
Osteosarcoma, NOS (C40._, C41._)
Oxyphilic adenoma
Paget's disease, mammary (C50._)
Papillary adenocarcinoma, NOS
Papillary carcinoma, NOS
Papillary serous cystadenocarcinoma (C56.9)
Papillary transitional cell carcinoma, non invasive (C67._)
Papillary transitional cell neoplasm of low malignant potential (C67._)
Pheochromocytoma, malignant (C74.1)
Phyllodes tumor, benign (C50._)
Pilocytic astrocytoma (C71._)
Pituitary adenoma, NOS (C75.1)
Pituitary carcinoma, NOS (C75.1)
Plasma cell leukemia (C42.1)
Pleomorphic adenoma
Pleomorphic xanthoastrocytoma (C71._)
Pleuropulmonary blastoma
Polycythemia vera
Precursor cell lymphoblastic leukemia, NOS
Precursor T-cell lymphoblastic leukemia
Precursor T-cell lymphoblastic lymphoma
Primary effusion lymphoma
Primitive neuroectodermal tumor, NOS (C71._)
Prolymphocytic leukemia, B-cell type
Prolymphocytic leukemia, NOS
Pterygium
Pulmonary blastoma (C34._)
Pulmonary sclerosing hemangioma
Refractory anemia with excess blasts
Refractory anemia with excess blasts in transformation
Refractory anemia with sideroblasts
Refractory anemia, NOS
Renal cell carcinoma, chromophobe type (C64.9)
Renal cell carcinoma, NOS (C64.9)
Renal cell carcinoma, sarcomatoid (C64.9)
Rhabdomyosarcoma, NOS
Sarcoma, NOS
Schneiderian carcinoma (C30.0, C31._)
Secretory carcinoma of breast (C50._)
Seminoma, NOS (C62._)
Serous cystadenocarcinoma, NOS (C56.9)
Serous cystadenoma, borderline malignancy (C56.9)
Serous cystadenoma, NOS (C56.9)
Serous surface papillary tumor of borderline malignancy (C56.9)
Serrated adenoma (C18._)
Signet ring cell carcinoma
Small cell carcinoma, NOS
Solid carcinoma, NOS
Solid pseudopapillary tumor (C25._)
Solitary fibrous tumor
Solitary fibrous tumor, malignant
Spindle cell carcinoma, NOS
Splenic marginal zone-B-cell lymphoma (C42.2)
Squamous cell carcinoma, NOS
Squamous cell carcinoma, small cell, nonkeratinizing
Squamous intraepithelial neoplasia, grade III
Subependymal giant cell astrocytoma (C71._)
Superficial spreading melanoma (C44._)
Sweat gland adenocarcinoma (C44._)
Synovial sarcoma, NOS
Teratoma, benign
Therapy-related acute myeloid leukemia, NOS
Therapy-related myelodysplastic syndrome
Thymic carcinoma, NOS (C37.9)
Transitional cell carcinoma, NOS
Tumor cells, benign
Tumor cells, NOS
Undifferentiated sarcoma
Urothelial papilloma, NOS

Argentina
Australia
Austria
Bangladesh
Belarus
Belgium
Brazil
Canada
Caribbean, NOS
Chile
China
China, Hong-Kong
Chinese Taipei (Taiwan)
Croatia
Czech Republic
Denmark
Egypt
Europe, NOS
Finland
France
Gambia
Germany
Greece
Hungary
Iceland
India
Indonesia
Iran
Ireland
Israel
Italy
Japan
Korea
Luxembourg
Malaysia
Mexico
More developed regions,NOS
Mozambique
New Zealand
Nigeria
Northern Africa, NOS
Northern America, NOS
Northern Europe, NOS
Norway
Papua New Guinea
Poland
Portugal
Russia
Saudi Arabia
Senegal
Serbia
Singapore
South Africa
South America, NOS
Spain
Sri Lanka
Sudan
Sweden
Switzerland
Thailand
The Netherlands
Tunisia
Turkey
Uganda
UK
Ukraine
Uruguay
USA
Vietnam
Western Africa, NOS
Western Europe, NOS
Yugoslavia

Australia/New Zealand
Caribbean
Central America
Eastern Africa
Eastern Asia
Eastern Europe
Melanesia
Northern Africa
Northern America
Northern Europe
South America
South Central Asia
South Eastern Asia
Southern Africa
Southern Europe
Western Africa
Western Asia
Western Europe

Exon 2
Exon 3
Exon 4
Exon 5
Exon 6
Exon 7
Exon 8
Exon 9
Exon 10
Exon 11